Difference between revisions of "Pracinostat (SB-939)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapy" to "Category:Chemotherapeutic") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapeutic" to "") |
||
| Line 6: | Line 6: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| − | + | ||
[[Category:Orphan drug]] | [[Category:Orphan drug]] | ||
Revision as of 22:23, 7 December 2019
Mechanism of action
HDAC inhibitor
History of changes in FDA indication
- 2/27/2014: Granted FDA orphan drug status for treatment of acute myeloid leulemia.